Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Digibug. Repositorio Institucional de la Universidad de Granada
Publication Artículo científico (JournalArticle)

A Novel, Quick, and Reliable Smartphone-Based Method for Serum PSA Quantification: Original Design of a Portable Microfluidic Immunosensor-Based System

  • Ortega, Francisco Gabriel
  • González Martínez, Coral
  • Valero Griñán, María Teresa|||0000-0002-3625-311X
  • Expósito Hernández, José
  • Puche, Ignacio
  • Rodríguez Martínez, Alba
  • Serrano Fernández, María José
  • Lorente Acosta, José Antonio|||0000-0002-9892-7386
We describe a versatile, portable, and simple platform that includes a microfluidic electrochemical immunosensor for prostate-specific antigen (PSA) detection. It is based on the covalent immobilization of the anti-PSA monoclonal antibody on magnetic microbeads retained in the central channel of a microfluidic device. Image flow cytometry and scanning electron microscopy were used to characterize the magnetic microbeads. A direct sandwich immunoassay (with horseradish peroxidase-conjugated PSA antibody) served to quantify the cancer biomarker in serum samples. The enzymatic product was detected at -100 mV by amperometry on sputtered thin-film electrodes. Electrochemical reaction produced a current proportional to the PSA level, with a linear range from 10 pg mL(-1) to 1500 pg mL(-1). The sensitivity was demonstrated by a detection limit of 2 pg mL(-1) and the reproducibility by a coefficient of variation of 6.16%. The clinical performance of this platform was tested in serum samples from patients with prostate cancer (PCa), observing high specificity and full correlation with gold standard determinations. In conclusion, this analytical platform is a promising tool for measuring PSA levels in patients with PCa, offering a high sensitivity and reduced variability. The small platform size and low cost of this quantitative methodology support its suitability for the fast and sensitive analysis of PSA and other circulating biomarkers in patients. Further research is warranted to verify these findings and explore its potential application at all healthcare levels., Universidad Nacional de San Luis PROICO 22/Q241, ANPCyT PICT 2018-04443 PICT-2015-2246 PICT-2015-1575 PICT-2014-1184 PICT-2014-0375 PICT-2018-04443, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) PIP 11220150100004CO, GENYO, Centre for Genomics and Oncological Research: Pfizer-University of Granada, Andalusian Regional Government (Granada, Spain), ISCIII Health Research Institute P17/00989, La Caixa Foundation, Health and Family Secretariat of the Andalusian Regional Government, Spanish Government, H2020-MSCA-IF-2019-895664
Digibug. Repositorio Institucional de la Universidad de Granada
Publication Artículo científico (JournalArticle)

Liquid biopsy biomarkers for accurate detection of malignant pulmonary nodules: a meta-analytic approach

  • Caballero Vázquez, Alberto
  • García Cerezo, Marta
  • Fernandez Castro, Laura R.
  • Morales-Garcia, Concepcion
  • Láinez-Ramos-Bossini, Antonio Jesús
  • Vergara Rubio, Fabian
  • Ortega Sánchez, Francisco Gabriel
  • Sánchez Maldonado, José Manuel
Pulmonary nodules are a common radiological finding that can be classified as either benign or Malignant, with significant clinical implications. The early detection of malignant nodules is critically important for improving the prognosis of lung cancer, which remains the leading cause of cancer-related mortality worldwide. Traditional imaging techniques have Limitations in accurately classifying pulmonary nodules. Liquid biopsy, a minimally invasive method that evaluates circulating components in the Blood, presents promising diagnostic potential in this context. This study aims to evaluate the diagnostic capacity of multiple liquid biopsy biomarkers for early and accurate differentiation between benign and Malignant pulmonary nodules. Accordingly, we conducted a comprehensive study involving a meta-analysis, selecting 16 eligible studies that utilised liquid biopsy to assess various circulating biomarkers in the diagnostic yield. The most significant results were linked to circulating free DNA (cfDNA). However, other components, including circulating tumour cells (CTCs), microRNAs/pfeRNAs, extracellular vesicles (EVs), serological markers, and imaging techniques, also provided valuable information. Similarly, integrating multi-omics data with machine learning models has been shown to enhance the ability to differentiate between benign and malignant pulmonary nodules, thereby supporting early diagnosis and improved management for patients with lung cancer., GENYO (Pfizer–University of Granada–Andalusian Regional Government), Instituto de Salud Carlos III - (PI22/01275, PI19/01578), University of Granada - (P32/22/02), Consejería de Salud y Familia, Junta de Andalucía - (RH-0074-2020), European Union’s Horizon 2020 - (H2020-MSCAeIFe2019-895664)
Digibug. Repositorio Institucional de la Universidad de Granada
Publication Artículo científico (JournalArticle)

In Cellulo Bioorthogonal Catalysis by Encapsulated AuPd Nanoalloys: Overcoming Intracellular Deactivation

  • Rubio Ruiz, Belén|||0000-0003-4720-6578
  • Ortega Liébana, M. Carmen
  • Valero Griñán, María Teresa|||0000-0002-3625-311X
Bioorthogonal metallocatalysis has opened up a xenobiotic route to perform nonenzymatic catalytic transformations in living settings. Despite their promising features, most metals are deactivated inside cells by a myriad of reactive biomolecules, including biogenic thiols, thereby limiting the catalytic functioning of these abiotic reagents. Here we report the development of cytocompatible alloyed AuPd nanoparticles with the capacity to elicit bioorthogonal depropargylations with high efficiency in biological media. We also show that the intracellular catalytic performance of these nanoalloys is significantly enhanced by protecting them following two different encapsulation methods. Encapsulation in mesoporous silica nanorods resulted in augmented catalyst reactivity, whereas the use of a biodegradable PLGA matrix increased nanoalloy delivery across the cell membrane. The functional potential of encapsulated AuPd was demonstrated by releasing the potent chemotherapy drug paclitaxel inside cancer cells. Nanoalloy encapsulation provides a novel methodology to develop nanoreactors capable of mediating new-to-life reactions in cells., UK Research & Innovation (UKRI), Engineering & Physical Sciences Research Council (EPSRC) EP/N021134/1, ERC (Advanced Grant CADENCE) ERC-2016-ADG-742684, European Commission European Commission Joint Research Centre H2020-MSCA-IF-2014-658833 H2020-MSCA-IF-2018-841990 H2020-MSCA-IF-2016-749299 H2020-MSCA-IF-2019-895664, Spanish Government RTI2018-099019-A-I00